Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-23 Sale | 2024-01-25 4:18 pm | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,707 | $950 | $2,571,650 | 6,382 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 4:16 pm | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 3,613 | $800 | $2,890,400 | 6,247 (Direct) | View |
| 2022-03-30 Sale | 2022-04-01 4:08 pm | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,431 | $700 | $1,701,700 | 6,082 (Direct) | View |
| 2021-09-10 Sale | 2021-09-13 4:01 pm | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,479 | $650 | $1,611,350 | 5,891 (Direct) | View |
| 2021-06-07 Sale | 2021-06-08 4:03 pm | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 1,930 | $525 | $1,013,250 | 8,322 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-02 Option Award | 2026-01-06 4:13 pm | N/A 2036-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,117 | $0 | 8,665 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:06 pm | N/A 2035-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,124 | $0 | 8,506 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-25 4:18 pm | N/A 2032-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,707 | $0 | 6,382 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-25 4:18 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,707 | $625.6 | 6,382 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:07 pm | N/A 2034-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 1,742 | $0 | 7,989 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 4:16 pm | N/A 2031-01-04 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 3,613 | $0 | 6,247 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 4:16 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 3,613 | $482.68 | 6,247 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:21 pm | N/A 2033-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,094 | $0 | 8,176 (Direct) | View |
| 2022-03-30 Exercise | 2022-04-01 4:08 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,431 | $374.12 | 6,082 (Direct) | View |
| 2022-03-30 Exercise | 2022-04-01 4:08 pm | N/A 2030-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,431 | $0 | 6,082 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:19 pm | N/A 2032-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,898 | $0 | 8,789 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-13 4:01 pm | N/A 2028-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,479 | $0 | 5,891 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-13 4:01 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,479 | $380.95 | 5,891 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 1,930 | $374.12 | 8,322 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 4:03 pm | N/A 2030-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 1,930 | $0 | 8,322 (Direct) | View |